Upstream Bio
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2023-12-31 |
|---|---|---|---|
Revenue | $613 | $607 | $450 |
Gross Profit | 613 | 607 | 450 |
EBITDA | -26,269 | -18,879 | -14,316 |
EBIT | -26,318 | -18,893 | -14,330 |
Net Income | -21,242 | -15,992 | -11,833 |
Net Change In Cash | 613 | 607 | 450 |
Free Cash Flow | -19,797 | -14,288 | -16,110 |
Cash | 325,892 | 32,948 | 25,833 |
Basic Shares | 53,603 | 51,341 | 51,341 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $2,370 | $2,380 | $1,212 |
Gross Profit | 2,370 | 2,380 | 1,212 |
EBITDA | -77,675 | -40,054 | -23,902 |
EBIT | -77,764 | -40,114 | -23,909 |
Net Income | -62,806 | -20,537 | -23,868 |
Net Change In Cash | 2,370 | 2,380 | 1,212 |
Free Cash Flow | -59,683 | -38,070 | -19,103 |
Cash | 325,892 | 25,833 | 17,051 |
Basic Shares | 53,603 | 36,323 | 36,323 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.40 |
2024-09-30 | -$6.96 |
